Selected research
Market Analysis & Forecast
Global Veterinary API Manufacturing Market Analysis and Forecast 2026-2032
Market perspective
The global Veterinary API Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Veterinary API Manufacturing include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA, Ofichem Group, NGL Fine-Chem Ltd., Menadiona, FIS - Fabbrica Italiana Sintetici S.p.A, Excel Industries Ltd. and Alivira Animal Health Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Veterinary API Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Veterinary API Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary API Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary API Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary API Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary API Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Veterinary API Manufacturing Segment by Company
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
Ofichem Group
NGL Fine-Chem Ltd.
Menadiona
FIS - Fabbrica Italiana Sintetici S.p.A
Excel Industries Ltd.
Alivira Animal Health Ltd.
Afton Pharma
Veterinary API Manufacturing Segment by Type
NSAIDs
Anti-infectives
Antiparasitic
Biologics
Vaccines
Others
Veterinary API Manufacturing Segment by Application
In House
Contract Outsourcing
Veterinary API Manufacturing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary API Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary API Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary API Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Veterinary API Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Veterinary API Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary API Manufacturing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAIDs
- Anti-infectives
- Antiparasitic
- Biologics
- Vaccines
- Others
Applications
- In House
- Contract Outsourcing
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- Jiangsu Lingyun Pharmaceutical Co., Ltd.
- SUANFARMA
- Ofichem Group
- NGL Fine-Chem Ltd.
- Menadiona
- FIS - Fabbrica Italiana Sintetici S.p.A
- Excel Industries Ltd.
- Alivira Animal Health Ltd.
- Afton Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Veterinary API Manufacturing Market by Type
- 1.2.1 Global Veterinary API Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 NSAIDs
- 1.2.3 Anti-infectives
- 1.2.4 Antiparasitic
- 1.2.5 Biologics
- 1.2.6 Vaccines
- 1.2.7 Others
- 1.3 Veterinary API Manufacturing Market by Application
- 1.3.1 Global Veterinary API Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 In House
- 1.3.3 Contract Outsourcing
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary API Manufacturing Market Dynamics
- 2.1 Veterinary API Manufacturing Industry Trends
- 2.2 Veterinary API Manufacturing Industry Drivers
- 2.3 Veterinary API Manufacturing Industry Opportunities and Challenges
- 2.4 Veterinary API Manufacturing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Veterinary API Manufacturing Market Perspective (2021-2032)
- 3.2 Global Veterinary API Manufacturing Growth Trends by Region
- 3.2.1 Global Veterinary API Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Veterinary API Manufacturing Market Size by Region (2021-2026)
- 3.2.3 Global Veterinary API Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Veterinary API Manufacturing Revenue by Players
- 4.1.1 Global Veterinary API Manufacturing Revenue by Players (2021-2026)
- 4.1.2 Global Veterinary API Manufacturing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Veterinary API Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Veterinary API Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Veterinary API Manufacturing Key Players Headquarters & Area Served
- 4.4 Global Veterinary API Manufacturing Players, Product Type & Application
- 4.5 Global Veterinary API Manufacturing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Veterinary API Manufacturing Market CR5 and HHI
- 4.6.3 2025 Veterinary API Manufacturing Tier 1, Tier 2, and Tier 3
5 Veterinary API Manufacturing Market Size by Type
- 5.1 Global Veterinary API Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary API Manufacturing Revenue by Type (2021-2032)
- 5.3 Global Veterinary API Manufacturing Revenue Market Share by Type (2021-2032)
6 Veterinary API Manufacturing Market Size by Application
- 6.1 Global Veterinary API Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Veterinary API Manufacturing Revenue by Application (2021-2032)
- 6.3 Global Veterinary API Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- 7.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information
- 7.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
- 7.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 7.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
- 7.2 Jiangsu Lingyun Pharmaceutical Co., Ltd.
- 7.2.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information
- 7.2.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
- 7.2.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.2.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 7.2.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
- 7.3 SUANFARMA
- 7.3.1 SUANFARMA Company Information
- 7.3.2 SUANFARMA Business Overview
- 7.3.3 SUANFARMA Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.3.4 SUANFARMA Veterinary API Manufacturing Product Portfolio
- 7.3.5 SUANFARMA Recent Developments
- 7.4 Ofichem Group
- 7.4.1 Ofichem Group Company Information
- 7.4.2 Ofichem Group Business Overview
- 7.4.3 Ofichem Group Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.4.4 Ofichem Group Veterinary API Manufacturing Product Portfolio
- 7.4.5 Ofichem Group Recent Developments
- 7.5 NGL Fine-Chem Ltd.
- 7.5.1 NGL Fine-Chem Ltd. Company Information
- 7.5.2 NGL Fine-Chem Ltd. Business Overview
- 7.5.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.5.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio
- 7.5.5 NGL Fine-Chem Ltd. Recent Developments
- 7.6 Menadiona
- 7.6.1 Menadiona Company Information
- 7.6.2 Menadiona Business Overview
- 7.6.3 Menadiona Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.6.4 Menadiona Veterinary API Manufacturing Product Portfolio
- 7.6.5 Menadiona Recent Developments
- 7.7 FIS - Fabbrica Italiana Sintetici S.p.A
- 7.7.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Information
- 7.7.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
- 7.7.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.7.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio
- 7.7.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
- 7.8 Excel Industries Ltd.
- 7.8.1 Excel Industries Ltd. Company Information
- 7.8.2 Excel Industries Ltd. Business Overview
- 7.8.3 Excel Industries Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.8.4 Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio
- 7.8.5 Excel Industries Ltd. Recent Developments
- 7.9 Alivira Animal Health Ltd.
- 7.9.1 Alivira Animal Health Ltd. Company Information
- 7.9.2 Alivira Animal Health Ltd. Business Overview
- 7.9.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.9.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio
- 7.9.5 Alivira Animal Health Ltd. Recent Developments
- 7.10 Afton Pharma
- 7.10.1 Afton Pharma Company Information
- 7.10.2 Afton Pharma Business Overview
- 7.10.3 Afton Pharma Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
- 7.10.4 Afton Pharma Veterinary API Manufacturing Product Portfolio
- 7.10.5 Afton Pharma Recent Developments
8 North America
- 8.1 North America Veterinary API Manufacturing Revenue (2021-2032)
- 8.2 North America Veterinary API Manufacturing Revenue by Type (2021-2032)
- 8.2.1 North America Veterinary API Manufacturing Revenue by Type (2021-2026)
- 8.2.2 North America Veterinary API Manufacturing Revenue by Type (2027-2032)
- 8.3 North America Veterinary API Manufacturing Revenue Share by Type (2021-2032)
- 8.4 North America Veterinary API Manufacturing Revenue by Application (2021-2032)
- 8.4.1 North America Veterinary API Manufacturing Revenue by Application (2021-2026)
- 8.4.2 North America Veterinary API Manufacturing Revenue by Application (2027-2032)
- 8.5 North America Veterinary API Manufacturing Revenue Share by Application (2021-2032)
- 8.6 North America Veterinary API Manufacturing Revenue by Country
- 8.6.1 North America Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Veterinary API Manufacturing Revenue by Country (2021-2026)
- 8.6.3 North America Veterinary API Manufacturing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Veterinary API Manufacturing Revenue (2021-2032)
- 9.2 Europe Veterinary API Manufacturing Revenue by Type (2021-2032)
- 9.2.1 Europe Veterinary API Manufacturing Revenue by Type (2021-2026)
- 9.2.2 Europe Veterinary API Manufacturing Revenue by Type (2027-2032)
- 9.3 Europe Veterinary API Manufacturing Revenue Share by Type (2021-2032)
- 9.4 Europe Veterinary API Manufacturing Revenue by Application (2021-2032)
- 9.4.1 Europe Veterinary API Manufacturing Revenue by Application (2021-2026)
- 9.4.2 Europe Veterinary API Manufacturing Revenue by Application (2027-2032)
- 9.5 Europe Veterinary API Manufacturing Revenue Share by Application (2021-2032)
- 9.6 Europe Veterinary API Manufacturing Revenue by Country
- 9.6.1 Europe Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Veterinary API Manufacturing Revenue by Country (2021-2026)
- 9.6.3 Europe Veterinary API Manufacturing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Veterinary API Manufacturing Revenue (2021-2032)
- 10.2 China Veterinary API Manufacturing Revenue by Type (2021-2032)
- 10.2.1 China Veterinary API Manufacturing Revenue by Type (2021-2026)
- 10.2.2 China Veterinary API Manufacturing Revenue by Type (2027-2032)
- 10.3 China Veterinary API Manufacturing Revenue Share by Type (2021-2032)
- 10.4 China Veterinary API Manufacturing Revenue by Application (2021-2032)
- 10.4.1 China Veterinary API Manufacturing Revenue by Application (2021-2026)
- 10.4.2 China Veterinary API Manufacturing Revenue by Application (2027-2032)
- 10.5 China Veterinary API Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Veterinary API Manufacturing Revenue (2021-2032)
- 11.2 Asia Veterinary API Manufacturing Revenue by Type (2021-2032)
- 11.2.1 Asia Veterinary API Manufacturing Revenue by Type (2021-2026)
- 11.2.2 Asia Veterinary API Manufacturing Revenue by Type (2027-2032)
- 11.3 Asia Veterinary API Manufacturing Revenue Share by Type (2021-2032)
- 11.4 Asia Veterinary API Manufacturing Revenue by Application (2021-2032)
- 11.4.1 Asia Veterinary API Manufacturing Revenue by Application (2021-2026)
- 11.4.2 Asia Veterinary API Manufacturing Revenue by Application (2027-2032)
- 11.5 Asia Veterinary API Manufacturing Revenue Share by Application (2021-2032)
- 11.6 Asia Veterinary API Manufacturing Revenue by Country
- 11.6.1 Asia Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Veterinary API Manufacturing Revenue by Country (2021-2026)
- 11.6.3 Asia Veterinary API Manufacturing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Veterinary API Manufacturing Revenue (2021-2032)
- 12.2 SAMEA Veterinary API Manufacturing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Veterinary API Manufacturing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Veterinary API Manufacturing Revenue by Type (2027-2032)
- 12.3 SAMEA Veterinary API Manufacturing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Veterinary API Manufacturing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Veterinary API Manufacturing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Veterinary API Manufacturing Revenue by Application (2027-2032)
- 12.5 SAMEA Veterinary API Manufacturing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Veterinary API Manufacturing Revenue by Country
- 12.6.1 SAMEA Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Veterinary API Manufacturing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Veterinary API Manufacturing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst